About Omnimol
Omnimol is a company based in Thane (India) founded in 2019. It operates as a B2B. Omnimol operates in a competitive market with competitors including Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
- Headquarter Thane, India
- SectorsHealthcare
- Website omnimolmeditechnics.com
- Legal Name Sanocytes Pharma Private Limited
- Date of Incorporation 12 Mar, 2019
- Jurisdiction Nashik, Maharashtra, India
- Annual Revenue₹0.50 Cr
FY 2024 · +138% YoY
- Net Profit₹0.00 Cr
FY 2024 · 0% margin
- EBITDA₹0.00 Cr
FY 2024 · 1% margin
Associated legal entities of Omnimol
Omnimol operates through Sanocytes Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sanocytes Pharma Private Limited CIN U85190MH2019PTC322436 | Active | 12 Mar 2019 | Nashik, Maharashtra | ₹0.5 Cr | – | 2 | View details |
Board of directors of Sanocytes Pharma Private Limited (Omnimol)
Sanocytes Pharma Private Limited is the primary company behind Omnimol. The board of Sanocytes Pharma Private Limited currently have 2 directors; the longest-serving is Amol Ashok Nimbalkar, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Amol Ashok Nimbalkar DIN 08387409 | Director | 12 Mar 2019 | 7 yrs 6 mo | Sanocytes Pharma Private Limited |
| Govind Prabhakar Pitrubhakta DIN 09364931 | Director | 19 Oct 2021 | 4 yrs 11 mo | Sanocytes Pharma Private Limited |
Financials of Omnimol
Figures of Sanocytes Pharma Private Limited, the primary company behind Omnimol, for FY 2024. Revenue was ₹0.50 Cr (+138% year on year). Net profit was ₹0.00 Cr (0% margin). EBITDA was ₹0.00 Cr (1% margin). Revenue has grown at a compounded annual rate of +10% over three years.
- ₹0.50 CrRevenue · FY 2024 · +138% YoY
- ₹0.00 CrNet profit · 0% margin
- ₹0.00 CrEBITDA · 1% margin
- ₹0.01 CrPaid-up capital
- +10%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Sanocytes Pharma Private Limited are on its company page.
Detailed financial statements for Omnimol
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Omnimol
Omnimol operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| zelgen.com | 2009 | Suzhou, China | $61.92M | – | Company developing small molecules & eukaryotic cell based recombinant protein drugs | |
| capsugel.com | 1875 | Morristown, United States | – | – | Dosage forms are delivered for preclinical, clinical, and commercial supply. | |
| adarepharmasolutions.com | 2015 | Lawrence Township, United States | – | 217 | CDMO manufacturing solid drugs | |
| cpc.com | 1971 | Hauppauge, United States | – | 27 | Product development, manufacturing and packaging services | |
| lotuspharm.com | 1966 | Taipei, Taiwan | – | – | Contract manufacturing for oral solid formulations is offered. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | – | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. | |
| vovantis.com | 2008 | Vadodara, India | – | 145 | Develops and manufactures novel effervescent drug delivery systems. | |
| glukembiocare.com | 2014 | Hyderabad, India | – | 234 | Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. |
Detailed competitors of Omnimol
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Omnimol
The website of Omnimol (omnimolmeditechnics.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Omnimol. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Omnimol
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Omnimol
10 companies that operate in the same segment as Omnimol (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Omnimol
Omnimol was founded in 2019.
Omnimol is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
The primary company behind Omnimol, Sanocytes Pharma Private Limited, reported revenue of ₹0.50 Cr for FY 2024, up 138% year on year.
Omnimol serves as a cdmo specializing in solid drug formulation manufacturing through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Omnimol's top competitors include Inventia Healthcare, Zim Labs and Lotus.
Omnimol operates through Sanocytes Pharma Private Limited.
The legal entities of Omnimol currently have 2 directors, including Amol Ashok Nimbalkar, Govind Prabhakar Pitrubhakta.
The website of Omnimol receives about 681 thousand visits a month.